Two URMC trainees earned CTSI pilot awards for 2013-2014. The CTSI’s pilot program offers trainees one-year awards for up to $25,000, to obtain new skills, develop technologies, generate critical preliminary clinical data, test new collaborative approaches, and create new outcome assessments and biomedical informatics advances. All UR pre-doctoral students, fellows and residents are eligible to apply. Click here to see the newly-released RFA for 2014 pilot awards. The 2013 trainee awardees are:
Hsi-min (Jim) Hsiao, BS, MS
Pathology and Laboratory Medicine
Novel pro-resolving lipid mediators reduce cigarette smoke-induced emphysema
Chronic obstructive pulmonary disease (COPD, emphysema and chronic bronchitis) is the fourth leading cause of death in the United States. Current therapies for COPD attempt to relieve the symptoms but do not alter the course of the disease; therefore, new therapies for COPD are desperately needed. This study will provide critical pre-clinical data needed to prepare for human clinical trials of resolvins in lung disease.
Jonathan Stone, BA, MD
Intraparenchymal Stent for Obstructive Hydrocephalus (IPSOH): a Novel Technology
Hydrocephalus is a common debilitating neurologic disease affecting a significant portion of the pediatric and adult population. The current surgical treatment options are frought with complications and excessive costs heralding the need for new technology. This project will not only test the efficacy of this new shunt system in an animal model, but will also evaluate the movement of interstitial fluid in hydrocephalus before and after interventions.